Guardant Health
GH
#2453
Rank
A$8.70 B
Marketcap
$70.50
Share price
-0.46%
Change (1 day)
177.02%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: A$8.70 Billion

As of April 2025 Guardant Health has a market cap of A$8.70 Billion. This makes Guardant Health the world's 2453th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025A$8.70 B43.91%
2024A$6.04 B25.47%
2023A$4.81 B17.7%
2022A$4.09 B-70.81%
2021A$14.02 B-16.3%
2020A$16.75 B59.88%
2019A$10.48 B129.04%
2018A$4.57 B

End of Day market cap according to different sources

On Apr 17th, 2025 the market cap of Guardant Health was reported to be:

A$8.70 Billion
by Nasdaq info icon info icon
A$8.70 Billion
by CompaniesMarketCap info icon info icon
A$8.70 Billion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
A$31.38 B 260.68%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.49 B-82.83%๐Ÿ‡บ๐Ÿ‡ธ USA